Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 4 5 Toe Cutaneous Syndactyly C5937268
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 4 5 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
4 5 Toe Cutaneous Syndactyly C5937268
Webbing between the 4th and 5th toes, present from birth. Usually mild and often does not affect walking. Treatment is typically not needed unless symptoms develop.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
4 5 Toe Cutaneous Syndactyly C5937268
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
4 5 Toe Cutaneous Syndactyly C5937268
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
4 5 Toe Cutaneous Syndactyly C5937268
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
4 5 Toe Cutaneous Syndactyly C5937268
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
4 5 Toe Cutaneous Syndactyly C5937268
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
4 5 Toe Cutaneous Syndactyly C5937268
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 4-5-toe-cutaneous-syndactyly-C5937268 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 4 5 Toe Cutaneous Syndactyly C5937268 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be present in an XX fetus after androgen exposure. | External genitalia are not the defining feature. | High |
| Toe webbing | Toe fusion is not a described feature of this condition. | Skin webbing between the fourth and fifth toes is present from birth. | High |
| Functional impact | May affect sex development and require specialist follow-up. | Usually mild and often does not affect walking. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
XX infant with atypical genitalia and maternal androgen medication history
The history and reproductive phenotype match the described exposure-related condition.
High
Need to stop an implicated androgen-containing medicine
Source guidance identifies stopping the offending agent as key, with specialist care.
Moderate
Endocrine rather than limb-anomaly evaluation
The supplied category is endocrine and the body system is reproductive.
Moderate
Choose 4 5 Toe Cutaneous Syndactyly C5937268 when
Isolated skin webbing of the fourth and fifth toes from birth
This matches the congenital musculoskeletal finding.
High
No walking limitation or other symptoms
Treatment is typically unnecessary unless symptoms develop.
Moderate
Genetic or congenital limb-anomaly classification
The supplied category is genetic and the body system is musculoskeletal.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 4 5 Toe Cutaneous Syndactyly C5937268 | Interpretation |
|---|---|---|---|
| Karyotype | XX chromosomal pattern is part of the concept. | No specific karyotype result is established. | XX status supports the left concept only with clinical and exposure context. |
| Medication and pregnancy history | Androgen-containing hormone exposure during pregnancy is relevant. | No maternal medication link is described. | History helps distinguish exposure-related development from a congenital toe finding. |
| Foot examination | No characteristic toe finding is established. | Cutaneous syndactyly between toes 4 and 5 is visible. | Physical examination is usually sufficient to identify the right finding. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Potentially serious developmental effects; exact prognosis is not established.
- Factors
- Timing and nature of exposure and specialist care may matter, but outcomes vary.
4 5 Toe Cutaneous Syndactyly C5937268
- Outcome
- Usually mild, with walking often preserved.
- Factors
- Symptoms, skin problems, or functional limitation may change management.
Time frame: Left onset is variable; right is present at birth. Both may be chronic.
Neither condition is communicable. Individual prognosis requires clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental effects | Fetal sex development may be affected; exact outcomes vary. Limb development is limited to toe webbing. Do not assume identical complications; specialist assessment is needed. |
| Mobility problems | Walking impairment is not established. Walking is often unaffected, but symptoms can occur. Functional complaints should be assessed individually. |
| Need for intervention | Stopping exposure and specialist infant care are emphasized. Intervention is usually not needed unless symptoms develop. No treatment dose or procedure is established here. |
Patient education highlights
- HighDifferent conditions
Atypical sex development after androgen exposure and toe webbing are unrelated findings.
- HighMedication exposure
Report pregnancy hormone or androgen use to clinicians; do not stop prescribed medicine without advice.
- MediumToe symptoms
Seek review if webbing causes pain, skin problems, footwear difficulty, or walking concerns.